Atlas Trials

Short-term Clinical Study of CN128 in Thalassemia Patients

Clinical trial NCT03935633 · COMPLETED

Trial details

NCT number
NCT03935633
Sponsor
Hangzhou Zede Pharma-Tech Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Thalassemia
Start date
2018-12-03
Primary completion
2019-05-06
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.